| pubmed-article:8574720 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8574720 | lifeskim:mentions | umls-concept:C0011991 | lld:lifeskim |
| pubmed-article:8574720 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:8574720 | lifeskim:mentions | umls-concept:C0023992 | lld:lifeskim |
| pubmed-article:8574720 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:8574720 | lifeskim:mentions | umls-concept:C1696465 | lld:lifeskim |
| pubmed-article:8574720 | lifeskim:mentions | umls-concept:C1883594 | lld:lifeskim |
| pubmed-article:8574720 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:8574720 | pubmed:dateCreated | 1996-3-8 | lld:pubmed |
| pubmed-article:8574720 | pubmed:abstractText | To compare zaldaride maleate, a calmodulin inhibitor with gastrointestinal antisecretory properties, with loperamide and a placebo in the treatment of travellers' diarrhoea. | lld:pubmed |
| pubmed-article:8574720 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8574720 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8574720 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8574720 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8574720 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8574720 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8574720 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8574720 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8574720 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:8574720 | pubmed:issn | 0954-691X | lld:pubmed |
| pubmed-article:8574720 | pubmed:author | pubmed-author:MurphyJ RJR | lld:pubmed |
| pubmed-article:8574720 | pubmed:author | pubmed-author:KilpatrickM... | lld:pubmed |
| pubmed-article:8574720 | pubmed:author | pubmed-author:SteffesMM | lld:pubmed |
| pubmed-article:8574720 | pubmed:author | pubmed-author:MouradA SAS | lld:pubmed |
| pubmed-article:8574720 | pubmed:author | pubmed-author:OyofoB ABA | lld:pubmed |
| pubmed-article:8574720 | pubmed:author | pubmed-author:SchickM TMT | lld:pubmed |
| pubmed-article:8574720 | pubmed:author | pubmed-author:GyurechDD | lld:pubmed |
| pubmed-article:8574720 | pubmed:author | pubmed-author:Silberschmidt... | lld:pubmed |
| pubmed-article:8574720 | pubmed:author | pubmed-author:el-EtrSS | lld:pubmed |
| pubmed-article:8574720 | pubmed:author | pubmed-author:MathewsonJ... | lld:pubmed |
| pubmed-article:8574720 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8574720 | pubmed:volume | 7 | lld:pubmed |
| pubmed-article:8574720 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8574720 | pubmed:authorsComplete | N | lld:pubmed |
| pubmed-article:8574720 | pubmed:pagination | 871-5 | lld:pubmed |
| pubmed-article:8574720 | pubmed:dateRevised | 2009-10-16 | lld:pubmed |
| pubmed-article:8574720 | pubmed:meshHeading | pubmed-meshheading:8574720-... | lld:pubmed |
| pubmed-article:8574720 | pubmed:meshHeading | pubmed-meshheading:8574720-... | lld:pubmed |
| pubmed-article:8574720 | pubmed:meshHeading | pubmed-meshheading:8574720-... | lld:pubmed |
| pubmed-article:8574720 | pubmed:meshHeading | pubmed-meshheading:8574720-... | lld:pubmed |
| pubmed-article:8574720 | pubmed:meshHeading | pubmed-meshheading:8574720-... | lld:pubmed |
| pubmed-article:8574720 | pubmed:meshHeading | pubmed-meshheading:8574720-... | lld:pubmed |
| pubmed-article:8574720 | pubmed:meshHeading | pubmed-meshheading:8574720-... | lld:pubmed |
| pubmed-article:8574720 | pubmed:meshHeading | pubmed-meshheading:8574720-... | lld:pubmed |
| pubmed-article:8574720 | pubmed:meshHeading | pubmed-meshheading:8574720-... | lld:pubmed |
| pubmed-article:8574720 | pubmed:meshHeading | pubmed-meshheading:8574720-... | lld:pubmed |
| pubmed-article:8574720 | pubmed:meshHeading | pubmed-meshheading:8574720-... | lld:pubmed |
| pubmed-article:8574720 | pubmed:meshHeading | pubmed-meshheading:8574720-... | lld:pubmed |
| pubmed-article:8574720 | pubmed:meshHeading | pubmed-meshheading:8574720-... | lld:pubmed |
| pubmed-article:8574720 | pubmed:meshHeading | pubmed-meshheading:8574720-... | lld:pubmed |
| pubmed-article:8574720 | pubmed:meshHeading | pubmed-meshheading:8574720-... | lld:pubmed |
| pubmed-article:8574720 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:8574720 | pubmed:articleTitle | Treatment of travellers' diarrhoea: zaldaride compared with loperamide and placebo. | lld:pubmed |
| pubmed-article:8574720 | pubmed:affiliation | Division of Epidemiology and Prevention of Communicable Diseases, University of Zurich, Switzerland. | lld:pubmed |
| pubmed-article:8574720 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8574720 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8574720 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8574720 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:8574720 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8574720 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8574720 | lld:pubmed |
